Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Appointed CFO
Quarterly results
Director departure
Appointed director

Echo Therapeutics, Inc. (ECTE) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/08/2021 REVOKED Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]:
04/21/2017 8-K Quarterly results
04/05/2017 SC 13D SCHOENBART ALAN WAYNE reports a 5.6% stake in ECHO THERAPEUTICS, INC.
03/31/2017 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
03/21/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/02/2017 8-K Form 8-K - Current report
12/27/2016 8-K Form 8-K - Current report
12/14/2016 8-K Form 8-K - Current report
12/02/2016 8-K Other Events
12/01/2016 8-K Form 8-K - Current report
11/23/2016 8-K Form 8-K - Current report
11/16/2016 10-Q Quarterly Report for the period ended September 30, 2016
11/14/2016 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
10/19/2016 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ...
Docs: "Promissory Note with Network Victory Limited"
09/27/2016 8-K Resignation/termination of a director
09/26/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
09/23/2016 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Promissory Note with Network Victory Limited",
"Separation Agreement, between Scott W. Hollander and Echo Therapeutics, Inc"
08/12/2016 10-Q Quarterly Report for the period ended June 30, 2016
07/08/2016 8-K Form 8-K - Current report
06/27/2016 EFFECT Form EFFECT - Notice of Effectiveness
06/10/2016 S-3 Form S-3 - Registration statement under Securities Act of 1933
06/03/2016 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Bylaws of Echo Therapeutics, Inc., as amended and restated as of June 1, 2016"
05/26/2016 8-K Submission of Matters to a Vote of Security Holders
05/20/2016 10-Q Quarterly Report for the period ended March 31, 2016
05/13/2016 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
05/06/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
05/04/2016 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister...
Docs: "Amendment to Certificate of Designation, Preferences and Rights of its Series F Convertible Preferred Stock",
"Form of Note",
"Form of Warrant",
"Promissory Note, issued to Beijing Yi Tang Bio Science & Technology, Ltd. by the Company",
"Promissory Note, issued to the Company by Beijing Yi Tang Bio Science & Technology, Ltd"
05/02/2016 EFFECT Form EFFECT - Notice of Effectiveness
04/19/2016 8-K Form 8-K - Current report
04/14/2016 8-K Form 8-K - Current report
04/14/2016 S-3 Form S-3 - Registration statement under Securities Act of 1933
04/13/2016 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/13/2016 DEF 14A Form DEF 14A - Other definitive proxy statements
04/06/2016 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy